mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.2 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |